Renaissance Technologies
EXAS

Renaissance Technologies’s Exact Sciences EXAS Stock Holding History

Renaissance Technologies’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,591,656
Closed -$162M – 3375
2025
Q4 		$162M Buy
1,591,656
+990,280
+165% +$79.5M 0.25% 83
2025
Q3 		$32.9M Buy
601,376
+72,572
+14% +$3.63M 0.04% 505
2025
Q2 		$28.1M Buy
528,804
+494,904
+1,460% +$25.1M 0.04% 565
2025
Q1 		$1.47M Buy
+33,900
New +$1.72M ﹤0.01% 2179
2024
Q4 		– Sell
-64,600
Closed -$4.4M – 3672
2024
Q3 		$4.4M Sell
64,600
-446,104
-87% -$25.2M 0.01% 1529
2024
Q2 		$21.6M Sell
510,704
-477,200
-48% -$26.3M 0.04% 556
2024
Q1 		$68.2M Buy
987,904
+37,000
+4% +$2.34M 0.11% 228
2023
Q4 		$70.3M Sell
950,904
-336,881
-26% -$22.1M 0.11% 225
2023
Q3 		$87.9M Buy
1,287,785
+678,485
+111% +$57.6M 0.15% 140
2023
Q2 		$57.2M Buy
609,300
+285,200
+88% +$22.2M 0.08% 280
2023
Q1 		$22M Buy
324,100
+220,800
+214% +$14.2M 0.03% 667
2022
Q4 		$5.11M Buy
103,300
+42,100
+69% +$1.72M 0.01% 1512
2022
Q3 		$1.99M Buy
+61,200
New +$2.52M ﹤0.01% 2009
2021
Q2 		– Sell
-82,904
Closed -$10.9M – 3548
2021
Q1 		$10.9M Sell
82,904
-527,300
-86% -$72.2M 0.01% 1137
2020
Q4 		$80.8M Buy
610,204
+467,874
+329% +$56.6M 0.09% 236
2020
Q3 		$14.5M Buy
+142,330
New +$12.3M 0.01% 912
2019
Q4 		– Sell
-519,800
Closed -$47M – 3562
2019
Q3 		$47M Buy
519,800
+128,240
+33% +$14.6M 0.04% 523
2019
Q2 		$46.2M Buy
391,560
+265,360
+210% +$26.7M 0.04% 527
2019
Q1 		$10.9M Buy
+126,200
New +$10.7M 0.01% 1324
2018
Q4 		– Sell
-249,198
Closed -$19.7M – 3436
2018
Q3 		$19.7M Buy
249,198
+162,898
+189% +$10.6M 0.02% 948
2018
Q2 		$5.16M Buy
+86,300
New +$4.64M 0.01% 1772
2017
Q4 		– Sell
-16,389
Closed -$772K – 3380
2017
Q3 		$772K Sell
16,389
-792,211
-98% -$31.9M ﹤0.01% 2665
2017
Q2 		$28.6M Buy
808,600
+457,300
+130% +$14.1M 0.04% 644
2017
Q1 		$8.3M Buy
+351,300
New +$6.96M 0.01% 1369
2016
Q4 		– Sell
-365,300
Closed -$6.78M – 3301
2016
Q3 		$6.78M Buy
+365,300
New +$6.44M 0.01% 1415
2016
Q2 		– Sell
-210,100
Closed -$1.42M – 3378
2016
Q1 		$1.42M Buy
210,100
+197,940
+1,628% +$1.27M ﹤0.01% 2413
2015
Q4 		$112K Buy
+12,160
New +$113K ﹤0.01% 3100

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Renaissance Technologies's EXAS Position: Q1 2026 in Review

Renaissance Technologies sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,591,656 shares — an estimated $162M sold.

Renaissance Technologies first reported a position in EXAS in Q4 2015 and held it in 27 quarters. The position peaked at $162M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Renaissance Technologies reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 1,591,656 Exact Sciences shares in Q1 2026, an estimated $162M.
  • Renaissance Technologies first reported a position in Exact Sciences in Q4 2015 and held it in 27 quarters.
  • Renaissance Technologies's Exact Sciences position peaked at $162M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.